-
PR
Professor Kenji Osafune, Chief Scientific Advisor, Presents at the 2025 Taiwan Regenerative Medicine Summit
-
PR
Rege Nephro Co., Ltd. Signs Collaborative Research Agreement with Fujifilm for the Development of a Human Kidney Chip
-
PR
The research group of Professor Kenji Osafune, Chief Scientific Advisor, has confirmed cell therapy efficacy in mouse model on chronic kidney disease (CKD) and published a research paper about the achievement
-
PR
Professor Kenji Osafune, Chief Scientific Advisor, Receives Award from the Japanese Society for Regenerative Medicine
-
PR
Akifumi Morinaka, Chief Executive Officer, Speaks at ‘JHVS Symposium for Medical Ventures and Academia’
-
Professor Kenji Osafune, Chief Scientific Advisor, Presents at the 2025 Taiwan Regenerative Medicine Summit
-
Rege Nephro Co., Ltd. Signs Collaborative Research Agreement with Fujifilm for the Development of a Human Kidney Chip
-
The research group of Professor Kenji Osafune, Chief Scientific Advisor, has confirmed cell therapy efficacy in mouse model on chronic kidney disease (CKD) and published a research paper about the achievement
-
Professor Kenji Osafune, Chief Scientific Advisor, Receives Award from the Japanese Society for Regenerative Medicine
-
Akifumi Morinaka, Chief Executive Officer, Speaks at ‘JHVS Symposium for Medical Ventures and Academia’
-
Upcoming Feature on NHK World JAPAN Science View: Freeing Patients from Dialysis! -Dr. Kenji OSAFUNE’s Challenge
-
Our business was introduced in Science Japan, an online magazine published by JST.
-
An article about Toshihiro Ishikiriyama, our president, was published in AnswersNews, serial column: Venture Round Visit Report.
-
Featured in Nikkei newspaper, its electronic version, Asahi Shimbun DIGITAL and many other media.
-
Published in the Nikkei newspaper and the electronic version.